| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2826.2003.00978.X |
| P8608 | Fatcat ID | release_chkwoc5emrbjlalbrr7qxvnzqu |
| P698 | PubMed publication ID | 12588512 |
| P5875 | ResearchGate publication ID | 10897928 |
| P50 | author | Andreas Kjær | Q39183738 |
| P2093 | author name string | J Warberg | |
| H Jørgensen | |||
| U Knigge | |||
| M Riis | |||
| P2860 | cites work | 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats | Q34167104 |
| Functional correlates of serotonin 5-HT1 recognition sites | Q34172554 | ||
| RS 23597-190: a potent and selective 5-HT4 receptor antagonist | Q36330377 | ||
| Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats | Q41774891 | ||
| The effect of serotonin agonist 1-(trifluoromethylphenly)-piperazine on corticotropin releasing factor and arginine vasopressin in rat hypothalamic nuclei | Q42452557 | ||
| Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin | Q42463455 | ||
| P433 | issue | 3 | |
| P921 | main subject | serotonin | Q167934 |
| oxytocin | Q169960 | ||
| AVP | Q12009087 | ||
| P304 | page(s) | 242-249 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Journal of Neuroendocrinology | Q3186929 |
| P1476 | title | Serotonin receptors involved in vasopressin and oxytocin secretion | |
| P478 | volume | 15 |
| Q34268490 | 3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates |
| Q30408983 | A Role for Oxytocin in the Etiology and Treatment of Schizophrenia |
| Q47783539 | A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder |
| Q42126695 | A refined high carbohydrate diet is associated with changes in the serotonin pathway and visceral obesity. |
| Q30544870 | Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor |
| Q37112840 | Acute responsivity of the serotonergic system to S-citalopram and positive emotionality-the moderating role of the 5-HTTLPR. |
| Q43128523 | Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test |
| Q37358657 | Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia |
| Q51818503 | Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. |
| Q48150130 | Effect of an increase in brain serotonin on the osmoregulatory response to a hypo- or hyperosmotic load in Wistar and vasopressin-deficient Brattleboro rats |
| Q57169376 | Effects of aggressive temperament on endogenous oxytocin levels in adult titi monkeys |
| Q27324786 | Empathic accuracy and oxytocin after tryptophan depletion in adults at risk for depression |
| Q37639133 | Escitalopram-Induced Amenorrhea and False Positive Urine Pregnancy Test |
| Q46116537 | Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice |
| Q36901254 | Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems |
| Q48172201 | Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat. |
| Q35680852 | From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions. |
| Q38740327 | Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures |
| Q36685572 | Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders |
| Q43166510 | Inhibitory effect of galanin on adrenaline- and noradrenaline-induced increased oxytocin secretion in rat neurohypophyseal cell cultures. |
| Q38674187 | Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis |
| Q47770844 | MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor. |
| Q38991468 | Magnocellular Neurons and Posterior Pituitary Function |
| Q36855609 | Neuronal serotonin in the regulation of maternal behavior in rodents |
| Q34267391 | New directions in the treatment of autism spectrum disorders from animal model research |
| Q28540131 | No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation |
| Q84146186 | Organizational effects of oxytocin on serotonin innervation |
| Q37218091 | Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial. |
| Q33664227 | Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible Treatment |
| Q39221067 | Oxytocin and opioid addiction revisited: old drug, new applications. |
| Q40765244 | Oxytocin and vasopressin hormone genes in children's externalizing problems: A cognitive endophenotype approach. |
| Q35009426 | Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders |
| Q50574443 | Oxytocin interference in the effects induced by inhalation of 7.5% CO(2) in healthy volunteers. |
| Q36913209 | Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting |
| Q64941735 | Oxytocin-dependent reopening of a social reward learning critical period with MDMA. |
| Q38442124 | Oxytocin: parallel processing in the social brain? |
| Q37367369 | Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms. |
| Q55039715 | Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial. |
| Q35073549 | Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study |
| Q28386367 | Prosocial effects of oxytocin in two mouse models of autism spectrum disorders |
| Q37107633 | Refining the Candidate Environment: Interpersonal Stress, the Serotonin Transporter Polymorphism, and Gene-Environment Interactions in Major Depression |
| Q36236061 | Regulation of oxytocin secretion |
| Q36878063 | Role of the serotoninergic system in the sodium appetite control |
| Q47695604 | Role of vasopressin V1a receptor in ∆9-tetrahydrocannabinol-induced cataleptic immobilization in mice |
| Q42869579 | Serotonin 1A agonism decreases affiliative behavior in pair-bonded titi monkeys |
| Q34140426 | Serotonin selectively influences moral judgment and behavior through effects on harm aversion |
| Q48364109 | Serotoninergic effects on judgments and social learning of trustworthiness |
| Q48396488 | Sertraline, a selective serotonin reuptake inhibitor, affects thirst, salt appetite and plasma levels of oxytocin and vasopressin in rats |
| Q24794352 | Severe symptomatic hyponatremia during citalopram therapy--a case report |
| Q88680221 | Sex differences in the ACTH and cortisol response to pharmacological probes are stressor-specific and occur regardless of alcohol dependence history |
| Q48253900 | Site of origin of and sex differences in the vasopressin innervation of the mouse (Mus musculus) brain. |
| Q64945674 | Social isolation rearing-induced anxiety and response to agomelatine in male and female rats: Role of corticosterone, oxytocin, and vasopressin. |
| Q37940904 | Sociality, pathogen avoidance, and the neuropeptides oxytocin and arginine vasopressin. |
| Q38822410 | Structural and functional diversity of nonapeptide hormones from an evolutionary perspective: A review. |
| Q33767701 | Switching brain serotonin with oxytocin |
| Q28392338 | The BTBR T+ tf/J mouse model for autism spectrum disorders-in search of biomarkers. |
| Q41417939 | The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish |
| Q38678068 | The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder |
| Q48398177 | The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects? |
| Q36353312 | The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies |
| Q36892246 | Variants in Adjacent Oxytocin/Vasopressin Gene Region and Associations with ASD Diagnosis and Other Autism Related Endophenotypes |
| Q57337534 | Variations in maternal 5-HTTLPR affect observed sensitive parenting |
| Q52289049 | Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. |
| Q33597191 | Vasopressin indirectly excites dorsal raphe serotonin neurons through activation of the vasopressin1A receptor |
| Q83970085 | [A 67-year-old patient with somnolence and severe hyponatraemia] |
Search more.